Catabasis Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Catabasis Pharmaceuticals Inc
TickerATXS
CIK #0001454789
CUSIP04635X102
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Kendall Square Bldg 1400E, Suite B14202, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001454789] 10-K
[0001454789] 10-Q
[0001454789] 3
[0001454789] 4
[0001454789] 5
[0001454789] 8-K
[0001454789] D
[0001454789] SC 13D
[0001454789] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Astria Therapeutics Inc [2025-06-18] 0.0
Forgrowth III PA BV Astria Therapeutics Inc [2025-01-07] 0.0
Vestal Point Capital LP Astria Therapeutics Inc [2024-11-14] 7.1
BlackRock Inc Astria Therapeutics Inc [2024-11-08] 6.2
Integrated Core Strategies US LLC Astria Therapeutics Inc [2024-11-01] 5.0
BlackRock Inc Astria Therapeutics Inc [2024-10-24] 6.2
Vanguard Group Inc Astria Therapeutics Inc [2024-02-13] 5.66
RA Capital Management LP Astria Therapeutics Inc [2024-02-12] 8.1
BlackRock Inc Astria Therapeutics Inc [2024-01-29] 6.0
TCG Crossover GP II LLC Astria Therapeutics Inc [2024-01-16] 0.9
Venrock Healthcare Capital Partners III LP Astria Therapeutics Inc [2024-01-02] 8.9
FMR LLC Astria Therapeutics Inc [2023-01-10] 0.0
Deep Track Capital LP Astria Therapeutics Inc [2022-12-22] 7.32
Altium Capital Management LP Astria Therapeutics Inc [2022-12-21] 5.2
Vivo Opportunity LLC Astria Therapeutics Inc [2022-09-08] 7.1
Cormorant Asset Management LP Astria Therapeutics Inc [2022-09-02] 5.38
Rosalind Advisors Inc Astria Therapeutics Inc [2022-01-07] 5.0
Viridian LLC Catabasis Pharmaceuticals Inc [2021-06-17] 0.99
Fairmount Funds Management LLC Catabasis Pharmaceuticals Inc [2021-06-17] 5.3
RA Capital Management LP Catabasis Pharmaceuticals Inc [2021-06-15] 7.5
Perceptive Advisors LLC Catabasis Pharmaceuticals Inc [2021-02-08] 10.5
BlackRock Inc Catabasis Pharmaceuticals Inc [2021-02-02] 5.8
Altium Capital Management LP Catabasis Pharmaceuticals Inc [2020-02-10] 7.4
Armistice Capital LLC Catabasis Pharmaceuticals Inc [2019-02-19] 4.99
Federated Investors Inc /PA/ Catabasis Pharmaceuticals Inc [2018-07-10] 14.7
Armistice Capital LLC Catabasis Pharmaceuticals Inc [2018-07-02] 4.99
Stonepine Capital Management LLC Catabasis Pharmaceuticals Inc [2018-06-28] 6.5
Empery Asset Management LP Catabasis Pharmaceuticals Inc [2018-06-25] 7.04
Corriente Advisors LLC Catabasis Pharmaceuticals Inc [2018-02-23] 7.3
Astrazeneca PLC Catabasis Pharmaceuticals Inc [2017-02-10] 10.7
Flynn James E Catabasis Pharmaceuticals Inc [2016-09-30] 4.21
Clarus Lifesciences II LP Catabasis Pharmaceuticals Inc [2016-02-19] 17.99
Advanced Technology Ventures VII LP Catabasis Pharmaceuticals Inc [2016-02-16] 7.4
FMR LLC Catabasis Pharmaceuticals Inc [2015-07-10] 0.0
SVLSF V LLC Catabasis Pharmaceuticals Inc [2015-07-08] 19.64
Camber Capital Management LLC Catabasis Pharmaceuticals Inc [2015-07-06] 6.38
Form 3/4/5 Filer 2011 - 2025
Lapointe Anthony Gregg
Astria Therapeutics, Inc.
Kishbauch Michael D
Cole Hugh M
Bate Kenneth
Agarwal Sunil
Callori Fred
Beck Joanne T.
Violin Jonathan
Komjathy Andrew
Morabito Christopher
Clauser Noah
Harshbarger Benjamin
Milne Jill C.
Matthews Andrea
Perceptive Life Sciences Master Fund Ltd
Perceptive Xontogeny Venture Fund, LP
Perceptive Advisors LLC
Edelman Joseph
Nichols Andrew John
Xontogeny, LLC
Adelman Burt A
Donovan Joanne M.
Cunnane Deirdre A.
George Jean
Ross Michael Jay
Hibben Edward K.
Modi Rick
Galakatos Nicholas
Sanderson Ian C.
Clarus Ventures II, LLC
Clarus Lifesciences II, L.P.
Clarus Ventures II GP, L.P.
SVLSF V LLC
SV Life Sciences Fund V Strategic Partners, L.P.
SV Life Sciences Fund V LP
SV Life Sciences Fund V (GP), LP
MedImmune Ventures, Inc.
Laufer Ron
Jirousek Michael
Advanced Technology Ventures VIII LP
ATV Associates VIII, L.L.C.
Form 13F Holdings
Firm Period DFND Voting Shares
Perceptive Advisors LLC [2025-06-30] SOLE 6,485,420 6,485,420
FMR LLC [2025-06-30] DFND 6,456,927 6,458,801
Vestal Point Capital LP [2025-06-30] SOLE 4,522,000 4,522,000
FCPM III Services BV [2025-06-30] DFND 0 4,107,537
BlackRock, Inc. [2025-06-30] SOLE 3,601,345 3,698,756
Fairmount Funds Management LLC [2025-06-30] SOLE 3,554,129 3,554,129
Millennium Management LLC [2025-06-30] SOLE 2,969,727 2,969,727
TCG Crossover Management LLC [2025-06-30] SOLE 2,761,861 2,761,861
Vanguard Group Inc [2025-06-30] SOLE 0 2,495,909
VR Adviser LLC [2025-06-30] SOLE 2,457,348 2,457,348
JPMorgan Chase & Co [2025-06-30] DFND 1,675,829 1,696,071
Vivo Capital LLC [2025-06-30] SOLE 1,552,685 1,552,685
Driehaus Capital Management LLC [2025-06-30] SOLE 1,097,417 1,419,333
Citadel Advisors LLC [2025-06-30] DFND 1,175,097 1,175,097
Nantahala Capital Management LLC [2025-06-30] SOLE 1,069,530 1,069,530
Geode Capital Management LLC [2025-06-30] DFND 963,938 963,938
State Street Corp [2025-06-30] DFND 877,720 934,120
Adage Capital Partners GP LLC [2025-06-30] SOLE 875,000 875,000
Point72 Asset Management LP [2025-06-30] DFND 0 762,756
UBS Group AG [2025-06-30] DFND 712,252 712,252
Logos Global Management LP [2025-06-30] SOLE 700,000 700,000
Morgan Stanley [2025-06-30] DFND 525,292 525,552
Nuveen, LLC [2025-06-30] DFND 369,390 369,390
Northern Trust Corp [2025-06-30] DFND 368,768 368,768
DAFNA Capital Management LLC [2025-06-30] SOLE 324,775 324,775
SIO Capital Management LLC [2025-06-30] SOLE 318,256 318,256
Charles Schwab Investment Management Inc [2025-06-30] SOLE 310,580 310,580
Affinity Asset Advisors LLC [2025-06-30] SOLE 300,000 300,000
Renaissance Technologies LLC [2025-06-30] SOLE 289,778 289,778
Sphera Funds Management Ltd [2025-06-30] DFND 257,402 257,402
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com